Skip to content
Life Sciences Series B Founded 2017

Aegicare

Developer of NGS-based genetic diagnostic devices. It is a molecular diagnostics company that offers whole-exome and whole-genome sequencing of normal and tumor tissue, respectively to detect inherited diseases, and assist physicians in the selection of therapy. The company has also developed HIVE, a clinical data management platform designed for clinical genomics. The company is also developing a genomics-based…

📍 Shenzhen, China · Genomics,

Funding snapshot

Last roundSeries B
Amount$15M
Date29 December 2020
Total raised$20M
Team size6

About

Developer of NGS-based genetic diagnostic devices. It is a molecular diagnostics company that offers whole-exome and whole-genome sequencing of normal and tumor tissue, respectively to detect inherited diseases, and assist physicians in the selection of therapy. The company has also developed HIVE, a clinical data management platform designed for clinical genomics. The company is also developing a genomics-based clinical decision support system. Founded in 2017, headquartered in Shenzhen, China. The company has raised $19.6M at the Series B stage backed by investors including Vinno Capital, DHVC, ASB Ventures, Insight Capital, Hengqin Financial Investment Group. Operating in Life Sciences > Genomics, Life Sciences > Clinical Genomics.

Business model

Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Portfolio of Sequencing-based Diagnostics

Institutional investors

Vinno Capital DHVC ASB Ventures Insight Capital Hengqin Financial Investment Group HMC Ventures

Latest coverage

No articles yet.

Raising like Aegicare?

Analyze your pitch deck before your next raise.

Analyze My Deck →